Budget Impact Analysis of the Introduction of New Therapeutic Agents for the Treatment of Metastatic Castration Resistant Prostate Cancer (MCRPC) Patients After Docetaxel Failure in the Brazilian Private Health System
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2204
https://www.valueinhealthjournal.com/article/S1098-3015(14)04134-5/fulltext
Title :
Budget Impact Analysis of the Introduction of New Therapeutic Agents for the Treatment of Metastatic Castration Resistant Prostate Cancer (MCRPC) Patients After Docetaxel Failure in the Brazilian Private Health System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04134-5&doi=10.1016/j.jval.2014.08.2204
First page :
A622
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1667